A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2001
11/22/2001	CA2398979A1 Novel bee venom polypeptides and methods of use thereof
11/21/2001	EP1156332A2 Assay methods for cyclin dependent kinases
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1156040A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
11/21/2001	EP1156039A1 Pyridazin-3-one derivatives and medicines containing the same
11/21/2001	EP1155119A1 Bhv-1 gene-deleted virus vaccine
11/21/2001	EP1155038A1 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
11/21/2001	EP1155037A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists therof, and their therapeutic uses
11/21/2001	EP1154988A1 Mevinolin derivatives
11/21/2001	EP1154797A2 Multi-mutant diphtheria toxin vaccines
11/21/2001	EP1154793A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
11/21/2001	EP1154789A2 Caulobacter lps immunoadjuvant
11/21/2001	EP1154785A2 Inhibitors for use in hemostasis and immune function
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP1154759A1 Dispersible concentrate for the delivery of cyclosporin
11/21/2001	EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001	EP0784622B1 Naphthyridinone derivatives
11/21/2001	EP0711305B1 Protegrins
11/21/2001	CN1323348A Delivery system for porcine somatotropin
11/21/2001	CN1323345A A modified polypeptide with reduced immune response
11/21/2001	CN1323314A Inhibitors of caspases
11/21/2001	CN1323310A Photocyclized rapamycins
11/21/2001	CN1323309A Phenyl yanthine derivatives
11/21/2001	CN1323307A 1H-imidazopyridine derivatives
11/21/2001	CN1323302A N-cimidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists
11/21/2001	CN1323294A Cyclic ester or amide derivatives
11/21/2001	CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001	CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
11/21/2001	CN1323217A Methods for therapeutic vaccination
11/21/2001	CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001	CN1323206A Fumaric acid microtablets
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1323186A Two chamber cartridge for atomizers
11/21/2001	CN1322818A New polypeptide human class-II aminoacyl-tRNA synthetase 10 and encoding polynucleotide of the same polypeptide
11/21/2001	CN1322752A New polypeptide human Pax protein 22 and its encoding polynucleotides
11/21/2001	CN1322749A New polypeptide human ribosomal protein S18-12 and its encoding polynucleotide
11/21/2001	CN1322745A New polypeptide human gap junction protein 15 and its encoding polynucleotide
11/21/2001	CN1075078C Producing process of stem cell factor
11/21/2001	CN1074932C Ophthalmic compositions
11/20/2001	US6320036 GbpA
11/20/2001	US6320022 Adrenomedullin peptides
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001	US6319910 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
11/20/2001	US6319906 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	CA2071971C The use of arginine as an immunostimulator
11/20/2001	CA2018287C Use of rapamycin for preparing a composition for inhibiting organ or tissue transplant rejection, and composition for inhibiting transplant rejection
11/18/2001	CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/18/2001	CA2477192A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/15/2001	WO2001085986A2 Phosphatidyl inositol 3-kinase delta binding partner
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085917A2 A device
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085792A2 Mu-1, member of the cytokine receptor family
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085778A1 A new polypeptide -human tubulin folding cofactor c13 and the polynucleotide encoding it
11/15/2001	WO2001085766A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001	WO2001085763A2 Chimeric peptide immunogens their preparation and use
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	WO2001085721A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	WO2001085209A2 Treating t-cell mediated diseases by modulating dr6 activity
11/15/2001	WO2001085208A2 Molecular antigen arrays and vaccines
11/15/2001	WO2001085207A2 Modulation of antigen processing using phagocytic cells
11/15/2001	WO2001085206A2 Immunosuppressive compositions comprising an immunophilin-binding compound and a gingkolide compound
11/15/2001	WO2001085205A1 Compositions and methods for induction of active autoimmunity
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085202A2 Electroporation for introduction of molecules into cells
11/15/2001	WO2001085196A2 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001	WO2001085194A1 Method and composition for the treatment of angiogenesis
11/15/2001	WO2001085191A1 Hyaluronidase activity and allergenic cell activity inhibitor
11/15/2001	WO2001085185A2 Treatment of il-10 deficiencies
11/15/2001	WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001	WO2001085156A1 Dermal compositions containing coenzyme q as the active ingredient
11/15/2001	WO2001085154A2 Method of treating immune pathologies with low dose estrogen
11/15/2001	WO2001085148A2 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride
11/15/2001	WO2001085096A2 Mast cell regulation
11/15/2001	WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001	WO2001017555A3 Food grade saponins as oral adjuvants
11/15/2001	WO2001006756A3 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
11/15/2001	WO2001004344A3 Induction of a th1-like response in vitro
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001	WO2000058365A9 Specific binding proteins for treating canine allergy
11/15/2001	WO2000045834A9 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease

1 ... 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 ... 1172